For decades, the United States has been a champion of the global drug control treaty system, which limits the use of marijuana exclusively to medical and scientific purposes, and obligates governments to punish and even criminalize recreational marijuana activity. But American attitudes toward marijuana policy are shifting: voters in Colorado and Washington approved ballot initiatives to legalize regulated recreational marijuana in 2012, and recent polls suggest that the majority of Americans think marijuana use should be legalized.
In this edition, the 5th Latin American and 1st Central American Conference on Drug Policy aims to be a platform for discussion and elaboration of solution-oriented proposals. The production and use of drugs is a complex phenomenon, with multiple manifestations according to the historical moment, cultural environment, economic model, the particular circumstances of a country, the different significances assigned by subjects, as well as the actual differences between substances. Nevertheless, it is reduced and homogenized as the “drug problem”, as if it was a uniform, unhistorical phenomenon.
The eleventh Informal Drug Policy Dialogue took place in Athens, co-organised by TNI and Diogenes Association. The programme incuded five sessions: (1) an overview of the national Greek drug policy and the drug situation in Greece, developments in drug policy in Greece; (2) the current state of affairs in Vienna; preparations for the CND high-level review and negotiations of the joint Ministerial Statement;(3) global cannabis policy developments; (4) the control of New Psychoactive Substances (NPS) ; (5) the road towards the upcoming UN General Assembly Special Session on Drugs (UNGASS on drugs) in 2016 has been discussed.
This side event will be an opportunity for Uruguay’s National Drugs Board to present the country’s new legislation, and open constructive debates on the implications of such policy at the national and international level.
The objective of this seminar is to compare the findings on innovative tools for the prevention of problematic cocaine use patterns, with experiences with harm reduction measures for stimulants in other regions of world.